Chris Serres: But, she really feels like, it put her, on a really safe path, to that point
This balances the benefits of weight or diabetes meds against stomach side effects
Because the original research concerned the gut, PLIVA tested it in the bowel disease ulcerative colitis, given as an enema, in a randomized, placebo-controlled study [11]
A total of 74 patients (56.1%) developed moderate-to-severe CIPN
The risk of nonarteritic anterior ischemic optic neuropathy (NAION) was not significantly different among those on GLP-1 drugs and those on other diabetes medicines
From an insurance perspective, side effects matter because dose adjustments or treatment interruptions can complicate ongoing prior authorizations